GMRE has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
GMRE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Global Medical REIT's change in receivables for the quarter that ended in Dec. 2024 was $0.7 Mil. It means Global Medical REIT's Accounts Receivable declined by $0.7 Mil from Sep. 2024 to Dec. 2024 .
Global Medical REIT's change in receivables for the fiscal year that ended in Dec. 2024 was $-1.5 Mil. It means Global Medical REIT's Accounts Receivable increased by $1.5 Mil from Dec. 2023 to Dec. 2024 .
Global Medical REIT's Accounts Receivable for the quarter that ended in Dec. 2024 was $7.4 Mil.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Global Medical REIT's Days Sales Outstanding for the three months ended in Dec. 2024 was 19.38.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Global Medical REIT's liquidation value for the three months ended in Dec. 2024 was $-688.2 Mil.
The historical data trend for Global Medical REIT's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Medical REIT Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
Change In Receivables | Get a 7-Day Free Trial |
![]() |
![]() |
-1.60 | -0.66 | -2.97 | 0.43 | -1.48 |
Global Medical REIT Quarterly Data | ||||||||||||||||||||
Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | |
Change In Receivables | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-0.98 | -1.15 | -0.05 | 0.70 | - |
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Medical REIT (NYSE:GMRE) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Global Medical REIT's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 7.424 | / | 34.952 | * | 91 |
= | 19.38 |
2. In Ben Graham's calculation of liquidation value, Global Medical REIT's accounts receivable are only considered to be worth 75% of book value:
Global Medical REIT's liquidation value for the quarter that ended in Dec. 2024 is calculated as:
Liquidation Value | |||||||
= | Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | + | (0.75 * Accounts Receivable) | + | (0.5 * Total Inventories) |
= | 6.815 | - | 700.57 | + | 0.75 * 7.424 | + | 0.5 * 0 |
= | -688.2 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Global Medical REIT's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
Moore Roscoe M Jr | director | C/O HEMOBIOTECH, INC., 5001 SPRING VALLEY ROAD, SUITE 1040 WEST, DALLAS TX 75244 |
Henry Cole | director | 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814 |
Jeffrey Busch | director, officer: Chairman, President and CEO | 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814 |
Lori Wittman | director | 191 NORTH WACKER DRIVE, SUITE 1200, CHICAGO IL 60606 |
Matthew Cypher | director | 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814 |
Paula Crowley | director | 2 BETHESDA METRO CENTER, SUITE 440, BETHESDA MD 20814 |
Ronald Marston | director | 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814 |
Robert J Kiernan | officer: Chief Financial Officer | 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814 |
Alfonzo Leon | officer: Chief Investment Officer | 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814 |
Danica Holley | officer: Chief Operating Officer | 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814 |
Jamie Allen Barber | officer: Secretary and General Counsel | 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814 |
Allen Webb | officer: SVP | 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814 |
Huiqi Zhang | director, 10 percent owner | 40-44 WYNDHAM STREET, 24/F WYNDHAM PLACE, HONG KONG K3 00000 |
Notable Reward Ltd | 10 percent owner | VISTRA CORPORATE SERVICES CENTRE, WICKHAMS CAY II, ROAD TOWN TORTOLA D8 VG1110 |
Superior Glory Enterprises Ltd. | 10 percent owner | VISTRA CORPORATE SERVICES CENTRE, WICKHAMS CAY II, ROAD TOWN TORTOLA D8 VG1110 |
From GuruFocus
By Business Wire • 01-08-2025
By GuruFocus Research • 08-06-2024
By Business Wire • 09-05-2024
By GuruFocus News • 10-09-2024
By GuruFocus Research • 02-27-2024
By Business Wire • 02-13-2025
By GuruFocus Research • 05-09-2024
By Business Wire • 09-17-2024
By GuruFocus News • 03-01-2025
By GuruFocus Research • 05-09-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.